RENT.COM.AU LIMITED — AGM Information 2010

May 5, 2010

ABN 25 062 063 692

Level 10 South Tower, 459 Collins St Melbourne Victoria 3000 Australia

Telephone +613 9613 4100 Facsimile +613 9613 4111 www.selectvaccines.com.au

April 28, 2010

Dear Shareholder,

The environment for commercialising new biomedical technologies has been especially challenging over the past 18 months following the global financial crisis. In particular, it has been very difficult for companies to raise new funds for early-stage (preclinical) development programs.

Accordingly, Select Vaccines elected to suspend its own vaccine development programs during 2009, operating on a care and maintenance basis to preserve funds. The Board has focused on securing a partnership arrangement with well-funded complementary companies in order to advance the development of the company's vaccine technology. At the same time, the Board has been seeking and investigating opportunities to acquire other businesses, principally but not exclusively in the medical sector.

The company is currently in discussions with a number of eligible, reputable parties that have expressed an interest in merging with Select with the condition that the combined entity would be able to have access to sufficient funds to advance its technology programs to a stage that will generate a significant uplift in shareholder value.

Yours faithfully

Shane Allan Chairman.

ABN 25 062 063 692

McLean Delmo Level 4, 302-320 Burwood Road Hawthorn, Vic 3122

Telephone +613 9613 4100 Facsimile +613 9613 4111 www.selectvaccines.com.au

NOTICE OF ANNUAL GENERAL MEETING

Incorporating Explanatory Memorandum and Proxy Form

Notice is given that an Annual General Meeting of Select Vaccines Limited will be held at

The Sebel Melbourne, 394 Collins Street, Melbourne, Victoria

on 27 May 2010 at 2.00 p.m.

Registration opening at 1.00 p.m.

ABN 25 062 063 692

NOTICE OF ANNUAL GENERAL MEETING

Notice is hereby given that an Annual General Meeting of the Members of Select Vaccines Limited (VCompanyW) will be held at the The Sebel Melbourne, 394 Collins Street, Melbourne, Victoria. on 27th May 2010 at 2.00 p.m.

BUSINESS OF THE ANNUAL GENERAL MEETING

ORDINARY BUSINESS

1. Financial Statements and Reports

To receive and consider the annual financial report of the Company and of the Economic Entity for the year ended 31 December 2010 and the reports by Directors and Auditors thereon.

To consider, and if thought fit, to pass, with or without amendment, the following ordinary resolutions:

2. Election of Directors

2.1 Re-Election of Dr Ian Cooke

VThat Dr Ian Cooke, who retires at the forthcoming Annual General Meeting in accordance with the Company\s Constitution and, being eligible, has offered himself for re-election as a Director of the Company.W

2.2 Re- Election of Mr George Weber

VThat Mr George Weber, who retires in accordance with the Company's constitution and, being eligible, offers himself for re-election, be re- elected as a Director of the Company.W

3. Non-Binding Adoption of Remuneration Report

VThat, members hereby adopt the 2010 Remuneration Report as published in the Directors\ Report section of the Company\s 2010 Annual Report.W

GENERAL BUSINESS

4. General Business

To transact any business that may be lawfully brought forward in accordance with the constitution.

BY ORDER OF THE BOARD

Richard Wadley Company Secretary April 28, 2010

ABN 25 062 063 692

The following Information for Shareholders and Notes set out below and the Explanatory Memorandum which accompanies this Notice of Meeting, form part of the Notice of Meeting.

INFORMATION FOR SHAREHOLDERS

NOTES:

1. Explanatory Memorandum

Further details of the resolutions in this Notice of Annual General Meeting are contained in the Explanatory Memorandum attached to and forming part of this Notice of Annual General Meeting. The Explanatory Memorandum should be read together with, and forms part of this Notice of Annual General Meeting.

2. Record Date

For the purposes of voting at this meeting, the Directors have determined that all shares of the Company that are quoted, or unquoted, securities at Noon AEST on Tuesday 25th May 2010 are taken to be held by persons who are registered as holding them at that time. The entitlement to vote at the meeting will be determined by reference to that time.

3. Proxies

Shareholders unable to attend the meeting can complete the attached Proxy Form and return it to the Company or to the Company\s Share Registry at the address or the facsimile numbers indicated in the Proxy Form no less than 48 hours before the time scheduled for the commencement of the meeting.

4. Voting In Person

Shareholders who plan to attend the meeting are asked to arrive at the venue 15 minutes prior to the time designated for the meeting, if possible, so that we may check shareholdings against the Share Register and note attendances.

5. Corporate Representatives

In order to vote in person at the meeting, a corporation that is a shareholder may appoint an individual to act as its representative. The appointment must comply with the requirements of Section 250D of the Corporations Act 2001. The representative should bring to the meeting evidence of their appointment, including any authority under which it is signed.

ABN 25 062 063 692

EXPLANATORY MEMORANDUM

This Explanatory Memorandum has been prepared for the information of Members of Select Vaccines Limited (the Company) in connection with the business to be conducted at the Annual General Meeting of Members to be held at The Sebel Melbourne, 394 Collins Street, Melbourne, Victoria. on 27th May 2010 at 2.00 p.m.

This Explanatory Memorandum should be read in conjunction with the accompanying Notice of Annual General Meeting.

Resolution 2.1 - Re-election of Dr Ian Cooke as a Director of the Company

Qualifications: BSc (Hons), PhD, M IP Law, MBA

Experience: Board member since 19 May 2004. Dr Cooke (aged 53) is the CEO of Foursight Associates Pty Ltd, a Melbourne-based life sciences and technology consultancy, where he provides advice to private equity funds and other clients regarding potential investments in the biotechnology arena. He was the Chief Executive Officer of CNSBio Pty Ltd and an Associate Director (Research & Development) at the Macfarlane Burnet Institute for Medical Research and Public Health where he was responsible for the overall management of the Burnet Institute's major research activities, with a particular focus on the commercialisation of emerging technologies developed by the Institute's scientist

Resolution 2.2 W Election of Mr George Weber

Qualifications: Associate of Arts Degree, University of Minnesota

Experience: Board member since 19 May 2004, Mr Weber (aged 66) has a strong background in the commercialisation of life sciences. Originally from the United States, Mr Weber worked with Eli Lilly and Johnson & Johnson in a variety of sales and management functions that included responsibility for the marketing and sales of pharmaceutical, instrumentation, implant and diagnostic products. The latter included responsibility for Hepatitis C tests marketed by Ortho-Clinical Diagnostics (a division of Johnson & Johnson) in conjunction with Chiron Inc. Since the early 1990s Mr Weber has run his own medical marketing consultancy. Clients have included ResMed Ltd, Universal Biosensors Pty Ltd and Chiron Inc. In July 2003, Mr Weber was appointed Managing Director of Chiron Vaccines Australia. Since its takeover by Novartis he has remained on as consultant to Novartis Vaccines until September 2009.

Resolution 3. Non-Binding Adoption of Remuneration Report

Pursuant to the Corporations Act 2001 the Annual General Meeting of a listed company must propose a resolution that the Remuneration Report be adopted. Also pursuant to the Corporation Act, the vote on this Resolution is advisory only and does not bind either the Directors or the Company.

The Remuneration Report is included in the Annual Report distributed to Shareholders and the Financial Statements are to be laid before the meeting. Shareholders will be given the opportunity to ask questions about or make comments on the Remuneration Report at the meeting.

DirectorsX recommendations

Each of the Directors recommends Shareholders vote in favour of all resolutions.

ABN 25 062 063 692

PROXY FORM

ShareholderXs Name

Please write you name(s) above

Appointment of Proxy

I/We appoint as proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, as the proxy or Chairman sees fit) at the Annual General Meeting (Meeting) of the Company to be held at The Sebel Melbourne, 394 Collins Street, Melbourne, Victoria. on 27th May 2010 at 2.00 p.m. (and at any adjournment thereof).

If the Chairman of the Meeting is to be your proxy and you have not directed your proxy how to vote on the items below, please mark this box. By marking this box you acknowledge that the Chairman of the Meeting may exercise your proxy even if he has an interest in the outcome of any of these items and that votes cast by him, other than as proxy holder, would be disregarded because of that interest. If you do not mark this box, and you have not directed your proxy how to vote, the Chairman of the Meeting will not cast your votes on these items and your votes will not be counted in computing the required majority if a poll is called on these items. The Chairman of the Meeting intends to vote undirected proxies he is entitled to cast in favour of these items.

		Or	the Chairman of the meeting
Name of person you are appointing (if not the meeting's Chairman)
		For		Against	Abstain
2.1	Election of Dr. Ian Cooke
2.2	Election of Mr George Weber
3	Adoption of Remuneration Report
•If you mark the Abstain box for a particular item, you are directing your proxy not to vote onyour behalf on a show of hands or on a poll and your votes will not be counted in computingthe required majority on a poll.Appointing a Second Proxy
		Or	%
	The number of shares applicable to this			The percentage of your voting
proxy form			rights
Contact Telephone Number
	Area CodeTelephone Number
	Signature(s)
	Shareholder 1	Shareholder 2			Shareholder 3

Shareholder 1	Shareholder 2	Shareholder 3
Director	Director/Secretary	Sole Director and Secretary

ABN 25 062 063 692

Company Seal (if required) Proxies may be lodged by fax on (03) 9529 2622, mail to or delivery to the registered office of the Company at McLean Delmo, Level 4, 302-320 Burwood Road, Hawthorn, Victoria, 3122. To be valid, a proxy form must and any applicable power of attorney (if not previously noted by the Company) be received by the registered office of the Company not less than 48 hours before the time appointed for the Annual General Meeting. For assistance in completing this form, please refer to the accompanying instructions.

INSTRUCTIONS FOR COMPLETION OF THE PROXY FORM

ShareholderXs Name

This is the name of the shareholder as it appears on the Company\s share register. For the purposes of this Meeting, shares will be taken to be held by those persons who are registered as holding them at 5.00pm AEST on Wednesday 25th May 2010.

Appointment of Proxy

A shareholder entitled to attend and vote at the Meeting is entitled to appoint not more than two other persons (whether shareholders or not) as proxy or proxies to attend in the shareholder\s place at the Meeting. The proxy has the same right as the shareholder to speak and vote at the Meeting. If you leave this section blank, the Chairman of the meeting will be your proxy to vote your shares even if you attend the meeting (unless you revoke your proxy before the meeting).

Vote on Resolutions

You may direct your proxy how to vote by placing a mark in one of the boxes opposite the resolution/s you wish to direct your proxy to vote on. If you do so, all your shares will be voted in accordance with your direction. You can split your vote on any resolution/s by inserting the number/s of shares you wish to vote in the appropriate box/es. Please ensure you clearly mark the box in black or blue ink by placing a mark or the number of shares you are voting.

Appointing a Second Proxy

If a shareholder appoints two proxies, unless each proxy is appointed to represent a specified proportion of the shareholder\s voting rights, each proxy may exercise half the votes of the appointor.

Contact Telephone

This will help us if there are any problems with your proxy form.

Signature(s)

Each shareholder must sign this form. If your shares are held in joint names, all shareholders must sign in the boxes. If you are signing as an Attorney, then the Power of Attorney must have been noted by the Company or be duly stamped and accompany this form. Only duly authorised officer/s can sign on behalf of a company. Please sign in the boxes provided which state the office held by the signatory.

This page has been left blank intentionally.

This page has been left blank intentionally.